Aegon USA Investment Management’s Summit Midstream SMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,124
Closed -$289K 42
2024
Q2
$289K Sell
8,124
-4,195
-34% -$132K 0.23% 26
2024
Q1
$346K Sell
12,319
-14,129
-53% -$264K 0.23% 24
2023
Q4
$474K Hold
26,448
0.34% 23
2023
Q3
$366K Buy
26,448
+515
+2% +$7.47K 0.26% 21
2023
Q2
$421K Hold
25,933
0.24% 27
2023
Q1
$398K Hold
25,933
0.22% 28
2022
Q4
$433K Hold
25,933
0.25% 29
2022
Q3
$390K Hold
25,933
0.23% 30
2022
Q2
$330K Sell
25,933
-1,563
-6% -$27.3K 0.18% 35
2022
Q1
$409K Buy
27,496
+8,208
+43% +$168K 0.19% 37
2021
Q4
$428K Buy
19,288
+9,900
+105% +$304K 0.12% 41
2021
Q3
$334K Sell
9,388
-4,657
-33% -$165K 0.1% 38
2021
Q2
$427K Sell
14,045
-1,531
-10% -$38.4K 0.13% 36
2021
Q1
$367K Sell
15,576
-7,283
-32% -$149K 0.12% 34
2020
Q4
$286K Sell
22,859
-1,626
-7% -$20.9K 0.09% 38
2020
Q3
$240K Buy
24,485
+3,615
+17% +$45.2K 0.08% 43
2020
Q2
$310K Buy
+20,870
New +$327K 0.12% 40

Other funds holding SMC

Aegon USA Investment Management's SMC Position: Q3 2024 in Review

Aegon USA Investment Management sold out of Summit Midstream (SMC) in Q3 2024, closing a stake of 8,124 shares — an estimated $289K sold.

Aegon USA Investment Management first reported a position in SMC in Q2 2020 and held it in 17 quarters. The position peaked at $474K in Q4 2023. 34 funds tracked by Wall St. Rank hold SMC as of Q3 2024.

  • Aegon USA Investment Management reported no remaining Summit Midstream position as of Q3 2024 after selling out during the quarter.
  • Aegon USA Investment Management sold 8,124 Summit Midstream shares in Q3 2024, an estimated $289K.
  • Aegon USA Investment Management first reported a position in Summit Midstream in Q2 2020 and held it in 17 quarters.
  • Aegon USA Investment Management's Summit Midstream position peaked at $474K in Q4 2023.
  • 34 funds tracked by Wall St. Rank held Summit Midstream as of Q3 2024.

Based on Aegon USA Investment Management's 13F filing for Q3 2024, filed 15 Oct 2024.